Ironwood Pharmaceuticals names Tammi Gaskins CEO
- Ironwood Pharmaceuticals (IRWD) announced on Friday the appointment of Chief Commercial Officer Tammi Gaskins as its new chief executive officer and a member of its board of directors, effective January 1, 2027.
- Gaskins will succeed Tom McCourt, who will retire as CEO but will remain a member of the board.
- Tammi has been a leader in Ironwood’s commercial organization since joining the company in 2020, playing a critical role in establishing LINZESS as the number one prescribed brand in the U.S. for the treatment of patients with irritable bowel syndrome with constipation or chronic idiopathic constipation, the company said.
- Source: Press Release
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.